Paul R Massey1, Sameer Gupta2, Brooke E Rothstein3, Nellie Konnikov4, Meera Mahalingam5, Emily S Ruiz1,4, Chrysalyne D Schmults1, Abigail Waldman6,7. 1. Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. 2. Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. 3. Department of Dermatology, Tufts Medical Center, Boston, MA, USA. 4. Department of Dermatology, Veterans Affairs, Boston Healthcare System, Boston, MA, USA. 5. Dermatopathology Section, Department of Pathology and Laboratory Medicine, Veterans Affairs, Boston Healthcare System, Boston, MA, USA. 6. Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. awaldman10@bwh.harvard.edu. 7. Department of Dermatology, Veterans Affairs, Boston Healthcare System, Boston, MA, USA. awaldman10@bwh.harvard.edu.
Abstract
BACKGROUND: Keratinocyte carcinoma (KC), including basal and squamous cell carcinoma, is the most common human malignancy. Limited real-world data have compared surgical outcome or cost between total margin-controlled excision (TMCE) and standard excision (SE), the two most common treatments for invasive KC. We compared reconstruction, margin status, and cost between TMCE and SE for KC on the nose at a Veterans Affairs (VA) healthcare system. METHODS: Randomly selected primary KCs on the nose ≤3 cm that were confined to soft tissue, without nerve or lymphovascular invasion, and treated with SE or TMCE between 2000 and 2010, were assessed. Utilization of flap or graft reconstruction and margin status following all surgical attempts were recorded. Costs were based on Current Procedural Terminology codes standardized to 2019 Medicare payments. RESULTS: Overall, 148 cases were included in each treatment group. Baseline characteristics were similar between groups, although SE tumor median diameter was 1 mm larger. SE was associated with increased utilization of flap or graft reconstruction (odds ratio 2.05, 95% confidence interval 1.16-3.59, p = 0.01). Positive margins were present in 24% of SEs initially and remained positive after the final recorded excision in 9% of cases. No positive final margins were noted in TMCE cases. SE cost per tumor was significantly higher than TMCE ($429.03 ± 143.55; p = 0.003). CONCLUSIONS: Surgical management of KC with SE is associated with increased reconstruction complexity, a significant risk of positive margins, and higher cost compared with TMCE. The 23% risk of positive margins supports National Comprehensive Cancer Network guidelines for the treatment of high-risk KC with TMCE, unless delayed reconstruction is employed.
BACKGROUND: Keratinocyte carcinoma (KC), including basal and squamous cell carcinoma, is the most common humanmalignancy. Limited real-world data have compared surgical outcome or cost between total margin-controlled excision (TMCE) and standard excision (SE), the two most common treatments for invasive KC. We compared reconstruction, margin status, and cost between TMCE and SE for KC on the nose at a Veterans Affairs (VA) healthcare system. METHODS: Randomly selected primary KCs on the nose ≤3 cm that were confined to soft tissue, without nerve or lymphovascular invasion, and treated with SE or TMCE between 2000 and 2010, were assessed. Utilization of flap or graft reconstruction and margin status following all surgical attempts were recorded. Costs were based on Current Procedural Terminology codes standardized to 2019 Medicare payments. RESULTS: Overall, 148 cases were included in each treatment group. Baseline characteristics were similar between groups, although SE tumor median diameter was 1 mm larger. SE was associated with increased utilization of flap or graft reconstruction (odds ratio 2.05, 95% confidence interval 1.16-3.59, p = 0.01). Positive margins were present in 24% of SEs initially and remained positive after the final recorded excision in 9% of cases. No positive final margins were noted in TMCE cases. SE cost per tumor was significantly higher than TMCE ($429.03 ± 143.55; p = 0.003). CONCLUSIONS: Surgical management of KC with SE is associated with increased reconstruction complexity, a significant risk of positive margins, and higher cost compared with TMCE. The 23% risk of positive margins supports National Comprehensive Cancer Network guidelines for the treatment of high-risk KC with TMCE, unless delayed reconstruction is employed.
Authors: Klara Mosterd; Gertruud A M Krekels; Fred Hm Nieman; Judith U Ostertag; Brigitte A B Essers; Carmen D Dirksen; Peter M Steijlen; Anton Vermeulen; Ham Neumann; Nicole W J Kelleners-Smeets Journal: Lancet Oncol Date: 2008-11-17 Impact factor: 41.316
Authors: David D Xiong; Brandon T Beal; Vamsi Varra; Marla Rodriguez; Hannah Cundall; Neil M Woody; Allison T Vidimos; Shlomo A Koyfman; Thomas J Knackstedt Journal: J Am Acad Dermatol Date: 2019-12-27 Impact factor: 11.527
Authors: Nicole W J Smeets; Gertruud A M Krekels; Judith U Ostertag; Brigitte A B Essers; Carmen D Dirksen; Fred H M Nieman; H A Martino Neumann Journal: Lancet Date: 2004 Nov 13-19 Impact factor: 79.321
Authors: Kevin M Burningham; Kim Le; Annie He; Madeleine O'Brian; Kevin Shi; Divya Srivastava; Rajiv I Nijhawan Journal: Arch Dermatol Res Date: 2022-10-21 Impact factor: 3.033